India’s Sitagliptin Wars Update: Glenmark On Market Only Until Q4 2015, Now

So — no interim relief for Glenmark, to dispose of its raw materials inventory — via continued manufacturing, from APIs. However, by most calculations, including mine, Glenmark has enough finished goods inventory to supply the Indian market demand for generic sitagliptin through November of 2015. And we should have a final outcome a month or so before then, in India in any event. [Backgrounder here.]

Here is the local coverage, just filed this afternoon, New York time:

. . . .A bench comprising justices Ranjan Gogoi and N. V. Ramana said it didn’t consider it appropriate to create additional rights in favour of Glenmark at this stage, when the Delhi High Court hearing on the dispute between Glenmark and US-based Merck, Sharpe and Dohme (MSD) is about to conclude.

“The registrar of the Delhi High Court is also directed to inform this court about the pending suit relating to the patent infringement after the judgement is delivered by the High Court,” the bench said. . . .

Onward, then on a hazy August Tuesday. . .

~~~~~~~~~~~

[Smiling — as I think of this day, exactly one year ago — and someone’s googly eyes. . . .]

Advertisements

There are no comments on this post.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: